Brief: Vincerx Pharma Posts Quarterly Loss Per Share $0.31
March 29 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
* EXPECTED CASH RUNWAY THROUGH 2023
* HAD $111.5 MILLION IN CASH AS OF DECEMBER 31, 2021, AS
COMPARED
TO $61.8 MILLION AS OF DECEMBER 31, 2020
* QTRLY LOSS PER SHARE $0.31
* Q4 REVENUE VIEW $0.00 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX834p8t
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign